# A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of IVT MHU650 in Macular Edema Patients

> **NCT04635800** · PHASE1 · COMPLETED · sponsor: **Novartis Pharmaceuticals** · enrollment: 21 (actual)

## Conditions studied

- Macular Edema
- Diabetic Macular Edema
- Neovascular Age-related Macular Degeneration
- Retinal Vein Occlusion

## Interventions

- **DRUG:** MHU650

## Key facts

- **NCT ID:** NCT04635800
- **Lead sponsor:** Novartis Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-12-10
- **Primary completion:** 2022-05-24
- **Final completion:** 2022-05-24
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2025-05-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04635800

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04635800, "A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of IVT MHU650 in Macular Edema Patients". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04635800. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*